Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.2.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AZ.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AZ.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.270ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.270ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.270ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.270NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.227ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.227ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.227ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.227NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
U.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
U.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
U.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
U.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.177.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.236ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.236ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.236ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.236NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.153ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.153ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.153ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.153NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.302ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.302ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.302ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.302NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.194ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.194ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.194ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.194NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.55ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.55NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.51ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used